April 08, 2021

Liva Healthcare collaborates with consortium of EU bodies to provide innovative cardiac rehabilitation

Liva Healthcare, a European market leader in scalable digital health coaching, has announced its participation in a new partnership collaboration initiative to make cardiac rehabilitation accessible to more patients in the immediate aftermath of a heart attack. Liva Healthcare is part of a consortium of EU bodies led by Amgen, a worldwide pioneer in biotechnology, to co-create an innovative digital tele-rehabilitation solution called Rehab+.

The European Institute of Innovation and Technology (EIT) Health recently announced that Rehab+ has won a prestigious Education Award, which enables Rehab+ to be implemented in four rehabilitation centres across Spain and the Netherlands and evaluated by Maastricht University (Center for Cardiology Research). Based on the scientific evaluation, further uptake of Rehab+ in Netherlands, Spain and additional countries will be discussed.

Rehab+ supports patients for over one year, helping them to transition from a passive, recovery mindset into an active one of self-care. Rehab+ is designed to help individuals assess their lifestyle post-heart attack, set personal objectives to reduce their cardiac risk, and establish long-lasting positive lifestyle changes. Rehab+ supports and equips patients to stay engaged with their own health and to manage their cardiac risk factors as a chronic condition to prevent a next heart attack.

A consortium to future-proof cardiac rehabilitation

To develop Rehab+, Amgen collaborated with Liva Healthcare, rehabilitation hospitals in Spain, La Paz in Madrid, Vall d’Hebron in Barcelona, Virgen de la Victoria in Malaga and Zuyderland in the Netherlands. Amgen also partnered with regional payors in Spain, Servicio Madrileño de Salud (SERMAS), Servicio Andaluz de Salud (SAS) and Servicio Català de la Salut (Cat Salut), and Maastricht University in the Netherlands. Rehab+ is endorsed by Spanish Society of Cardiology (SEC), Netherlands Society of Cardiology (NVVC) and Foro Español de Pacientes (Spanish Patients Forum).

Liva Healthcare will provide the technology platform, including the patient app. Through the app, patients will have regular support from a professional human coach and receive educational content based on their personal needs and situation. Patients can also track their own progress real-time and engage with a support group of peers to keep them motivated.

Rehab+ is part of OPTIMISE, an Amgen-led cardiovascular programme which aims to transform patient care and demonstrate improvement in outcomes. This is achieved through a wide range of innovative initiatives which support the healthcare community and patients at high risk of cardiovascular disease.

Roman Stampfli, Vice President Marketing & Innovation at Amgen, says:

“Only a third of the one million people who have a heart attack each year in Europe have access to cardiac rehabilitation to reduce their risk of a second heart attack,” says Roman Stampfli, Vice President Marketing & Innovation at Amgen. “This consortium is part of our commitment to make cardiac rehabilitation accessible to more patients in the immediate aftermath of a heart attack. By collaborating with Liva Healthcare and the consortium of EU partners, we can co-create an innovative digital tele-rehab solution that helps people establish long-lasting lifestyle changes.”

André Sode, CEO of Liva Healthcare, says:

“Amgen is addressing a significant gap in cardiac recovery. We are delighted to collaborate with Amgen, and a powerful collective of purpose-driven organisations, to help improve the lives of people who have had a heart attack,” says André Sode, CEO of Liva Healthcare. “By combining our technology and the expertise of Amgen and the consortium of partners, we can make cardiac rehabilitation easily accessible to more people, empowering them to stay engaged with their own health and, ultimately, reduce their risk of a next heart attack.”


Contact  

Jonas Damsgaard, Head of PR & Communications, jdj@livahealth.com

Related articles

Oktober 21, 2021

Liva Healthcare appoints Dr Naresh Kanumilli to power innovation in diabetes digital health coaching
Dr Kanumilli has been appointed as UK Medical Director for the digital health coaching company. Liva Healthcare (Liva), a European market leader in scalable digital health coaching, has appointed Dr Naresh Kanumilli as its new UK Medical Director. Leading the medical supervision of Liva in the UK, Dr Kanumilli will be responsible for liaising with […]
Read more

September 09, 2021

Liva Healthcare gewinnt den eHealth-Wettbewerb von Healthy Hub und erhält Zugang zu innovativen Partnerschaften mit deutschen Krankenkassen
Am Dienstag, den 1. April 2021, startete Healthy Hub seinen Call für Innovatoren aus dem deutschen eHealth-Bereich. Mehr als 100 Unternehmen aus dem Digital-Health-Bereich haben sich für den dritten Healthy Hub-Wettbewerb beworben, wobei es nur 15 eHealth-Anbieter in die Live-Pitches schafften. „Die interessantesten Bewerber laden wir zu Live-Pitches ein. Im Anschluss an eine persönliche Vorstellung der Ideen werden […]
Read more

Juni 24, 2021

Liva Healthcare bringt führende digitale Gesundheitsberatung zur Prävention und Behandlung von Diabetes und Übergewicht nach Deutschland
Kopenhagen, 24. Juni 2021. – Das dänische Unternehmen Liva Healthcare („Liva“), ein führender europäischer Anbieter von digitaler Gesundheitsberatung zur Prävention und Behandlung von Typ-2-Diabetes und Adipositas, gibt heute seine Expansion nach Deutschland bekannt. Geschäftsführer für den deutschen Markt ist der Arzt und Health-Unternehmer Dr. med. Philipp M. Schäfer. Das Health-Tech-Unternehmen mit Sitz in Kopenhagen und […]
Read more

April 08, 2021

Liva Healthcare collaborates with consortium of EU bodies to provide innovative cardiac rehabilitation
Liva Healthcare, a European market leader in scalable digital health coaching, has announced its participation in a new partnership collaboration initiative to make cardiac rehabilitation accessible to more patients in the immediate aftermath of a heart attack. Liva Healthcare is part of a consortium of EU bodies led by Amgen, a worldwide pioneer in biotechnology, […]
Read more